Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
drugs
fda
life sciences
national blog main
the institute for clinical and economic review
akcea therapeutics
alnylam pharmaceuticals
amgen
barry greene
boston
boston blog main
boston top stories
boston university
calcitonin gene-related peptide
chronic migraine
dan ollendorf
eli lilly
episodic migraine
hereditary transthyretin amyloidosis
indiana
indiana blog main
indiana top stories
inotersen
john berk
mary o'donnell
migraine
national top stories
new york blog main
new york top stories
patisiran
regeneron pharmaceuticals
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
teva pharmaceutical
What
decision
2
×
fda
ago
alnylam
announced
approval
approve
approved
awaits
biological
class
crossed
decades
developed
discovered
drug
eli
fingers
friday
headache
historic
late
lilly
marks
medicine
medicines
migraine
new
pain
patients
prevent
rna
starts
thursday
time
trick
uses
won
Language
Current search:
decision
×
biotech
×
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
